Research library/Emerging & Experimental
Category 12 of 12:
Emerging & Experimental
Early-stage research and debated treatments — where the science is still catching up to what families are already trying.
9 therapies · 2 groups · 5 reviews published
How we grade the evidence:
Neurostimulation
Non-invasive approaches to directly influence brain activity — still early, still being studied.
Transcranial Magnetic Stimulation (TMS)
Non-invasive magnetic pulses targeting specific brain regions to modulate neural circuits.
Neurofeedback (EEG Biofeedback)
Real-time brainwave feedback training to modulate attention, arousal, and connectivity.
Low-Energy Neurofeedback System (LENS)
Ultra-low-power electromagnetic signals used to "reset" brainwave patterns.
Photobiomodulation (Light Therapy)
One small sham-controlled trial found a positive signal on behavior, but certainty is very low from a single study.
Biomedical Frontiers
Investigational, body-wide approaches — some promising, some carrying real safety concerns.
Gut Microbiome Transplant (Microbiota Transfer Therapy)
Shows an early, weak signal for easing GI symptoms; placebo-controlled results on core traits are mixed.
Stem Cell Therapy
Infusion of cord blood or mesenchymal stem cells to modulate immune/neurological function.
Oxytocin Therapy
The largest, best-run trial found no meaningful benefit of intranasal oxytocin on social communication.
Bumetanide
The two largest, most careful trials found no improvement in core autism traits, and the manufacturer stopped development.
Chelation Therapy
Has caused documented harm, including deaths, by stripping essential minerals from the body. Not recommended.